Conjugated linoleic acid (CLA) modulates prostaglandin E2 (PGE2) signaling in canine mammary cells. 2006

Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
Department of Veterinary Biosciences, College of Veterinary Medicine, The Ohio State University, Columbus, OH 43210, USA.

BACKGROUND Conjugated linoleic acid (CLA), a naturally occurring linoleic acid isomer found in ruminant-produced foods, has the potential to serve as an effective chemopreventive nutriceutical factor for breast cancer prevention based upon previous published studies. There are several CLA isomers in ruminant-produced food products, among which t10,c12-CLA and c9,t11-CLA are more potent. Expression of cyclooxygenase 2 (COX-2) in mammary tumors has been correlated with poor prognosis. Prostaglandin E2 (PGE2) is a major COX-2 product in various cancers and, as in humans, PGE2 concentrations in canine tumor tissues were frequently elevated. Moreover, a PGE2 receptor subtype, EP2, is highly expressed in mammary tumors. Thus, various studies have implicated the important role of PGE2 and EP2 in COX-2-regulated tumor development. METHODS Mammary tumor and normal mammary tissues were both collected from a female dog with mammary tumor. Both malignant and normal mammary tissues were subjected to isolation of epithelial and stromal cells. The effects of t10,c12-CLA and c9,t11-CLA on proliferation, as well as COX-2 and EP2 protein expression in canine mammary normal and cancerous cells, were detected by CellTiter 96 AQueous assay and Western blot assay, respectively. RESULTS Both t10,c12-CLA and c9,t11-CLA not only suppressed malignant mammary cell growth, but also exerted inhibitory effects on tumor-associated non-malignant mammary cells. Similarly, both t10,c12-CLA and c9,t11-CLA suppressed EP2 protein expression in both normal and malignant mammary cells. t10,c12-CLA was more effective in decreasing COX-2 protein expression in malignant mammary cells, while, in contrast, c9,t11-CLA down-regulated COX-2 protein expression in both normal and malignant mammary cells. CONCLUSIONS The results indicate that the dietary component CLA regulates COX-2 and EP2 protein expression in both malignant mammary cells and cells from the tumor-associated stromal compartment. In turn, this may suppress PGE2 signaling, leading to better prognosis. We further speculate that the knowledge obtained from canine studies may also be beneficial to study human breast cancer.

UI MeSH Term Description Entries
D004283 Dog Diseases Diseases of the domestic dog (Canis familiaris). This term does not include diseases of wild dogs, WOLVES; FOXES; and other Canidae for which the heading CARNIVORA is used. Canine Diseases,Canine Disease,Disease, Canine,Disease, Dog,Diseases, Canine,Diseases, Dog,Dog Disease
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015232 Dinoprostone The most common and most biologically active of the mammalian prostaglandins. It exhibits most biological activities characteristic of prostaglandins and has been used extensively as an oxytocic agent. The compound also displays a protective effect on the intestinal mucosa. PGE2,PGE2alpha,Prostaglandin E2,Prostaglandin E2alpha,PGE2 alpha,Prepidil Gel,Prostaglandin E2 alpha,Prostenon,E2 alpha, Prostaglandin,E2, Prostaglandin,E2alpha, Prostaglandin,Gel, Prepidil,alpha, PGE2,alpha, Prostaglandin E2
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D015674 Mammary Neoplasms, Animal Tumors or cancer of the MAMMARY GLAND in animals (MAMMARY GLANDS, ANIMAL). Animal Mammary Carcinoma,Mammary Carcinoma, Animal,Mammary Neoplasms,Neoplasms, Mammary,Animal Mammary Carcinomas,Animal Mammary Neoplasm,Animal Mammary Neoplasms,Carcinoma, Animal Mammary,Carcinomas, Animal Mammary,Mammary Carcinomas, Animal,Mammary Neoplasm,Mammary Neoplasm, Animal,Neoplasm, Animal Mammary,Neoplasm, Mammary,Neoplasms, Animal Mammary
D044243 Linoleic Acids, Conjugated A collective term for a group of around nine geometric and positional isomers of LINOLEIC ACID in which the trans/cis double bonds are conjugated, where double bonds alternate with single bonds. Conjugated Linoleic Acid,Conjugated Linoleic Acid (CLA),Acid, Conjugated Linoleic,Acids, Conjugated Linoleic,Conjugated Linoleic Acids,Linoleic Acid, Conjugated
D051546 Cyclooxygenase 2 An inducibly-expressed subtype of prostaglandin-endoperoxide synthase. It plays an important role in many cellular processes and INFLAMMATION. It is the target of COX2 INHIBITORS. COX-2 Prostaglandin Synthase,Cyclo-Oxygenase II,Cyclooxygenase-2,PGHS-2,PTGS2,Prostaglandin H Synthase-2,COX 2 Prostaglandin Synthase,Cyclo Oxygenase II,Prostaglandin H Synthase 2,Prostaglandin Synthase, COX-2,Synthase, COX-2 Prostaglandin

Related Publications

Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
March 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
October 2007, Public health nutrition,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
April 2001, Lipids,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
January 2000, Anticancer research,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
January 2014, Obesity research & clinical practice,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
January 2008, Nutrition research and practice,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
January 2021, Methods in molecular biology (Clifton, N.J.),
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
February 2001, Obesity research,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
January 2012, Critical reviews in food science and nutrition,
Li-Shu Wang, and Yi-Wen Huang, and Suling Liu, and Hsiang-Lin Chang, and Weiping Ye, and Sherry Shu, and Yasuro Sugimoto, and Julie A Funk, and Daniel D Smeaks, and Lawrence N Hill, and Young C Lin
August 2003, European journal of medical research,
Copied contents to your clipboard!